Skip to content

GlaxoSmithKline plc Price, Chart & Factor Analysis

Free Data & Analytics Access

Next earnings: Wed, Feb 3, 2027, before the market opens · estimates and history

GlaxoSmithKline plc · E.GSKN.MX · Mexico
Use symbol E.GSKN.MX in our API & Excel add-in to retrieve this data ↓
938.00
(+0.10%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 75%
Bubble Risk LOW
Realised Volatility (20D) 36.64%

GlaxoSmithKline plc Forecast

GlaxoSmithKline plc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 36.6% a year, a typical one-standard-deviation range is 889.58–986.42 over a week, 838.78–1,037 over a month and 594.28–1,282 over a year. (Signals as of 5 Nov 2026.)

GlaxoSmithKline plc Price Chart

MacroFinance.ai

GlaxoSmithKline plc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
GlaxoSmithKline plc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
GlaxoSmithKline plc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
GlaxoSmithKline plc
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for GlaxoSmithKline plc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on GlaxoSmithKline plc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

GlaxoSmithKline plc Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to GlaxoSmithKline plc; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

About GlaxoSmithKline plc (Mexico)

GlaxoSmithKline plc is a listed security in Mexico. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is GlaxoSmithKline plc?
GlaxoSmithKline plc is a listed security in Mexico. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the trading strategies that hold it and free historical data.
What is the latest GlaxoSmithKline plc price?
The latest close is 938 (5 Nov 2026), +0.10% on the day. The price at the top of the page refreshes during the trading day.
Is GlaxoSmithKline plc in an uptrend?
As of 5 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (7 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is GlaxoSmithKline plc?
20-day realised volatility is 36.6% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 10.6% over a month and 5.2% over a week.
What factors affect GlaxoSmithKline plc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to GlaxoSmithKline plc, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade GlaxoSmithKline plc?
28 backtested tactical asset allocation strategies trade GlaxoSmithKline plc through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
Where can I download free GlaxoSmithKline plc historical data?
In the Free historical data section of this page: the last 10 years of GlaxoSmithKline plc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free GlaxoSmithKline plc historical data (last 10 years)

Browse or instantly download the last 10 years of GlaxoSmithKline plc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.GSKN.MX&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-19960
2026-11-18960
2026-11-17960
2026-11-13960
2026-11-12959.548
2026-11-11959.548
2026-11-10959.548
2026-11-09959.548
2026-11-06951.621
2026-11-05929.813
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.